Farther Finance Advisors LLC Lowers Stock Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
Farther Finance Advisors LLC decreased its holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 52.8% in the 4th quarter, HoldingsChannel reports. The firm owned 764 shares of the biopharmaceutical company’s stock after selling 856 shares during the quarter. Farther Finance Advisors LLC’s holdings in Halozyme Therapeutics were worth $37,000 as of its most […]
Farther Finance Advisors LLC decreased its holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 52.8% in the 4th quarter, HoldingsChannel reports. The firm owned 764 shares of the biopharmaceutical company’s stock after selling 856 shares during the quarter. Farther Finance Advisors LLC’s holdings in Halozyme Therapeutics were worth $37,000 as of its most […]
